Medicare Enrolled

Dr. Shahzad Hashmi, M.D.,

Psychiatry · Gainesville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
200 WISTERIA DR, Gainesville, GA 30501
7702195407
In practice since 2005 (20 years)
NPI: 1770566341 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hashmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hashmi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hashmi

Dr. Shahzad Hashmi is a psychiatry specialist in Gainesville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hashmi performed 3,828 Medicare services across 916 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hashmi received a total of $63,070 from 45 pharmaceutical and/or device companies across 1813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hashmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in GA $63,070 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,828
Medicare services
Top 0% in GA for psychiatry
916
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~191 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
1,180 $51 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,128 $93 $200
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
899 $60 $142
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
191 $64 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $62 $151
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
77 $61 $142
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
66 $129 $400
New patient office visit, complex (60-74 min) 54 $160 $450
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
51 $133 $250
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
23 $18 $86
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$63,070
Total received (2018-2024)
Avg $9,010/year across 7 years
Top 3% in GA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
1,813
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,758 (53.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,160 (36.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,153 (9.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,845
2023
$21,708
2022
$17,045
2021
$3,859
2020
$2,646
2019
$2,725
2018
$2,243

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$6,876
Supernus Pharmaceuticals, Inc.
$1,183
Neurocrine Biosciences, Inc.
$721
Alkermes, Inc.
$631
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$612
Teva Pharmaceuticals USA, Inc.
$581
Lundbeck LLC
$358
ABBVIE INC.
$302
Indivior Inc.
$248
Corium, LLC
$244
Bausch Health US, LLC
$236
CATALYST PHARMACEUTICALS, INC.
$223
Vanda Pharmaceuticals Inc.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$148
E.R. Squibb & Sons, L.L.C.
$99
Janssen Pharmaceuticals, Inc
$79
Noven Therapeutics, LLC
$54
Tris Pharma Inc
$42
IDORSIA PHARMACEUTICALS US INC
$23
Top 3 companies account for 68.4% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$22,007
Supernus Pharmaceuticals, Inc.
$8,465
Alkermes, Inc.
$7,502
Indivior Inc.
$6,616
Teva Pharmaceuticals USA, Inc.
$2,317
Neurocrine Biosciences, Inc.
$1,743
Lundbeck LLC
$1,585
Vanda Pharmaceuticals Inc.
$1,483
Janssen Pharmaceuticals, Inc
$1,249
Sunovion Pharmaceuticals Inc.
$1,232
Axsome Therapeutics, Inc.
$1,072
ABBVIE INC.
$1,055
ITI, Inc.
$794
Corium, LLC
$782
AbbVie Inc.
$615
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$612
Allergan Inc.
$569
Takeda Pharmaceuticals U.S.A., Inc.
$499
Avanir Pharmaceuticals, Inc.
$458
Bausch Health US, LLC
$435
Allergan, Inc.
$228
CATALYST PHARMACEUTICALS, INC.
$223
Eisai Inc.
$211
Tris Pharma Inc
$161
ACADIA Pharmaceuticals Inc
$157
Noven Therapeutics, LLC
$142
E.R. Squibb & Sons, L.L.C.
$99
OWP Pharmaceuticals, Inc.
$99
ARBOR PHARMACEUTICALS, INC.
$88
JAZZ PHARMACEUTICALS INC.
$67
Vertical Pharmaceuticals, LLC
$64
Shire North American Group Inc
$58
Merck Sharp & Dohme Corporation
$55
Ironshore Pharmaceuticals Inc.
$52
Corium, Inc.
$49
Azurity Pharmaceuticals, Inc.
$32
Neuronetics, Inc.
$30
Neos Therapeutics, LP
$29
Otsuka Pharmaceutical Development & Commercialization, Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$23
Catalyst Pharmaceuticals, Inc.
$21
Brainsway USA INC
$21
Novartis Pharmaceuticals Corporation
$18
Adlon Therapeutics L.P.
$17
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · AIMOVIG · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BOTOX · BRINTELLIX · CAPLYTA · COBENFY · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · Entyvio · Evekeo · Evekeo ODT · FANAPT · FYCOMPA · Fanapt · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · Lamotrigine Starter Kit · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · NUPLAZID · Nuedexta · OSMOLEX ER · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillivant XR · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUBLOCADE · SUNOSI · Secuado · Subvenite · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · WELLBUTRIN · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for psychiatry in GA.

Looking for a psychiatry specialist in Gainesville?
Compare psychiatrists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
57
Per 100K population
27.4
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hashmi is a clinical cardiology specialist, with above-average Medicare volume (top 0% in GA), with speaking/promotional industry engagement in the top 3% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hashmi experienced with psychotherapy and evaluation, 30 minutes?
Based on Medicare claims data, Dr. Hashmi performed 1,180 psychotherapy and evaluation, 30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hashmi receive payments from pharmaceutical companies?
Yes. Dr. Hashmi received a total of $63,070 from 45 companies across 1,813 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hashmi's costs compare to other psychiatrists in Gainesville?
Dr. Hashmi's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hashmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →